All those with new #rheum fellows: the Resources page of the American College of Rheumatology RA Toolkit (ratoolkit.kotobee.com/#/reader) has a great tutorial on how to do a joint exam and trainings on completing RA disease activity scores like CDAI.

This is an incredible opportunity for a post doc to join our growing Division and work on a signature project.

My thoughts on hydroxychloroquine dosing based on reviewing the evidence. See what you think! ⬇️ The #Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in #Rheumatology Practice acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar… Mike Putman Gabby Schmajuk Christie Bartels MD MS

Look at the slopes of #infliximab biosimilar uptake in the Private market and #Medicaid, and then look at #Medicare. Our research letter, using American College of Rheumatology #RISEregistry data, explores these trends and discusses why Medicare is falling behind.

Grateful to all the rheumatologists and patients who helped us create the American College of Rheumatology RA Toolkit.

Pls spread the word — we need #SLE pts to help with this study! Pls retweet this CreakyJoints.org Lupus Research Lupus Foundation of America Jinoos Yazdany Alfred Kim (moving to Bluesky as alhkim) Dr. Rachel Tate Dr. John Cush Amanda G

THIS SATURDAY! Don't miss Drs. Yazdany and Dhanranaji discuss adult and pediatric SLE updates and best practices. Register for free and watch from home, or better yet, at a local watch party with other rheumatology clinicians in your community. Have you registered yet? Learn

Congratulations Rheum Cat 🐈‍⬛. You worked hard for this and are extremely deserving of NIH support!!! 👏👏👏

2 great talks in 2 days and an amazing session with our fellows sharing so much wisdom. Thank you for visiting us Dr. Georg Schett!

Our work in AC&R Jinoos Yazdany Gabby Schmajuk @NamrataRheum

Enhancing Health Care Affordability: Strategies for Accelerating Biosimilar Uptake Editorial on the below study in A&R acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

So proud of our ACR 2024 Distinguished Fellow Dr. John Huizar!

Great talk on building more equitable future in lupus care and outcome. #ACR24

💡 #ACR24: A study found significant variation in #biosimilar uptake and switching at the practice level, indicating that “local switching policies are likely key drivers" of biosimilar use Find out more from investigator Dr. Eric Roberts UCSF Rheumatology👇 healio.com/news/rheumatol…

We are thrilled to welcome 4 outstanding rheumatology fellows to UCSF in 2025. The future of rheumatology is bright! Kara Lau Lianne Sarah Goglin Jinoos Yazdany Gabby Schmajuk UCSF Department of Medicine UC San Francisco #Match2024

🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UC San Francisco. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-ya… Jinoos Yazdany

Thanks #LUPUS2025 for the invitation, it was an honor to talk about what to do when we have to stop #HCQ with Guillermo Pons Estel Jinoos Yazdany Karen Costenbader and Antonio Aviña-Zubieta

Abstract #0189: Rheumatologists are early adopters and high utilizers of #AI scribes. 📊 Adoption: 41% 🧑‍💻 Retention: 100% 💬 High utilizers (> 70% visits): 83%. The highest among IM subspecialties 🕒 AI scribes reduced EHR time across all measures. Dr. John Cush #ACR25

Rheumatologists love AI scribes in clinic. The way we interact is potentially well suited, and accuracy and synthesis quality is bound to improve. Is it inevitable that it will universally be standard practice for us soon? UCSF clinics #ACR25 Jinoos Yazdany ABST0189 Dr. John Cush

#ACR25 Abstr#1526 Finally it’s here! Consensus-based guidance on GC #steroid tapering in patients with #SLE. Included considerations before tapering, tapering schedules and monitoring during tapering. Looking forward to the uptake and hearing patients’ views Dr. John Cush #ACRBest